Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06449378 · ClinicalTrials.gov registry record · NA
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
A NA study of Hernia and Hernia, Ventral, sponsored by Medtronic - MITG.
- Active
- Registry status
- NA
- Development phase
- 163
- Enrollment target
- 13
- Study locations
NCT06449378 is a NA study of Hernia and Hernia, Ventral that is active but no longer recruiting, run by Medtronic - MITG. The registered enrollment target is 163 participants, below the 188-participant average among 11 other Hernia trials with a reported enrollment target (13% lower). The trial reports 13 study locations across 6 states.
The verdict
NCT06449378, a NA study of Hernia and Hernia, Ventral, is active but no longer recruiting, sponsored by Medtronic - MITG.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk factor impairing wound healing) when used for reinforcement of abdominal wall soft tissues in procedures involving open extraperitoneal ventral hernia repair, in clean (US); and clean and clean-contaminated (Europe) surgical fields (Centers for Disease Control and Prevention (CDC) Classification I and II. Data from this study will primarily be used to support market approval and European post-market clinical follow-up needs. Secondarily, data will be used for product marketing, future product development, and to support market release and maintenance in global geographies.
Conditions Studied
Interventions
- DEVICE Transorb™ Self-Gripping Resorbable Mesh
Study Locations (13)
Other
- UZ Leuven, campus Gasthuisberg - Leuven
- APHP Hospital Louis Mourier - Colombes
- Centre Hospitalier Universitaire de Lille - Lille
- Hospices Civils de Lyon - Lyon
- Centre Hospitalier Universitaire de Reims - Reims
- Hôpital Charles Nicolle Centre Hospitalier Universitaire de Rouen - Rouen
- Hôpitaux Universitaires de Strasbourg - Strasbourg
Ohio
- Cleveland Clinic Foundation - Cleveland
- The Ohio State University - Columbus
Illinois
- Northwestern University - Evanston
Kentucky
- University of Kentucky - Lexington
North Carolina
- Novant Health New Hanover Regional Medical Center - Wilmington
Virginia
- TPMG General Surgery and Hernia Center - Newport News
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2030-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06449378
The ClinicalTrials.gov registry entry for NCT06449378 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 11 other Hernia trials with a reported enrollment target (13% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hernia appearing as the primary indexed condition, and to 1 intervention - of which Transorb™ Self-Gripping Resorbable Mesh is the first listed.
NCT06449378 reports 13 study locations spanning 6 distinct geographic areas - top geographies include Other, Ohio, Illinois.
Frequently Asked Questions
What is clinical trial NCT06449378 about?
NCT06449378 is a clinical study titled "Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia". The purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk factor impairing wound healing) when used for reinforcement of abdominal wall soft tissues in procedures involving open extraperitoneal ventral hernia ...
What is the current status of trial NCT06449378?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 163 participants. The study started on 2024-07-02. Estimated completion is 2030-10-01.
What conditions does trial NCT06449378 study?
This clinical trial studies the following conditions: Hernia, Hernia, Ventral, Hernia Abdominal Wall, Hernia, Abdominal.
What interventions are being tested in trial NCT06449378?
The interventions under investigation include: Transorb™ Self-Gripping Resorbable Mesh (DEVICE).
Who is sponsoring clinical trial NCT06449378?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06449378 being conducted?
This trial has 13 study locations across Illinois, Kentucky, North Carolina, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH
RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
Hernia Repair With or Without Sutures
COMPLETED · NA
-
Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation
COMPLETED · NA
-
Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery
COMPLETED · NA
-
CT and Radiologist RCT
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.